IRCT20090117001556N107
Recruiting
Phase 3
Sulforaphane treatment of autism spectrum disorder: a double blind controlled trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •DSM\-5 clinical diagnosis of autistic disorder
- •Children between the ages of 3 and 12 years old
- •Presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone)
Exclusion Criteria
- •Presence of any active medical problem
- •Other psychiatric diagnosis except for mild to moderate Intellectual disability
- •Receiving any antipsychotic medications during past monthprior to the trial
- •Severe hepatic disease
- •History of allergy to risperidone and intolerance of it
- •History of seizure requiring change of antiepileptic dose during the last month
- •Seizure during the last 6 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)Autism Spectrum DisorderNCT02561481University of Massachusetts, Worcester60
Active, not recruiting
Phase 2
Sulforaphane in a New Jersey (NJ) Population of Individuals With AutismAutismAutistic DisorderAutism Spectrum DisorderAutistic BehaviorNCT02677051Rutgers, The State University of New Jersey48
Recruiting
Not Applicable
Improving independence in driving for people with Autism Spectrum DisorderAutism Spectrum DisorderNeurological - Other neurological disordersMental Health - Autistic spectrum disordersACTRN12616001151426Hoe Lee60
Recruiting
Phase 2
Sulforaphane for the treatment of ADHDIRCT20090117001556N146Tehran University of Medical Sciences50
Recruiting
Not Applicable
Schema therapy for adults with autism and personality disorderschema therapy, adults, autism spectrum disorder, personality disorder, cognitive-behavioral, experientialschematherapie, volwassenen, autismespectrumstoornis, persoonlijkheidsstoornis, cognitief gedragstherapeutisch, experientieelNL-OMON28080Sarr expertise centre for autism (part of Parnassia group)Oudedijk 763062 AG RotterdamThe Netherlands12